Literature DB >> 24966085

Voluntary wheel running augments aortic l-arginine transport and endothelial function in rats with chronic kidney disease.

Christopher R Martens1, James M Kuczmarski2, Jahyun Kim1, John J Guers1, M Brennan Harris3, Shannon Lennon-Edwards4, David G Edwards5.   

Abstract

Reduced nitric oxide (NO) synthesis contributes to risk for cardiovascular disease in chronic kidney disease (CKD). Vascular uptake of the NO precursor l-arginine (ARG) is attenuated in rodents with CKD, resulting in reduced substrate availability for NO synthesis and impaired vascular function. We tested the effect of 4 wk of voluntary wheel running (RUN) and/or ARG supplementation on endothelium-dependent relaxation (EDR) in rats with CKD. Twelve-week-old male Sprague-Dawley rats underwent ⅚ ablation infarction surgery to induce CKD, or SHAM surgery as a control. Beginning 4 wk following surgery, CKD animals either remained sedentary (SED) or received one of the following interventions: supplemental ARG, RUN, or combined RUN+ARG. Animals were euthanized 8 wk after surgery, and EDR was assessed. EDR was significantly impaired in SED vs. SHAM animals after 8 wk, in response to ACh (10(-9)-10(-5) M) as indicated by a reduced area under the curve (AUC; 44.56 ± 9.01 vs 100 ± 4.58, P < 0.05) and reduced maximal response (Emax; 59.9 ± 9.67 vs. 94.31 ± 1.27%, P < 0.05). AUC was not improved by ARG treatment but was significantly improved above SED animals in both RUN and RUN+ARG-treated animals. Maximal relaxation was elevated above SED in RUN+ARG animals only. l-[(3)H]arginine uptake was impaired in both SED and ARG animals and was improved in RUN and RUN+ARG animals. The results suggest that voluntary wheel running is an effective therapy to improve vascular function in CKD and may be more beneficial when combined with l-arginine.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  chronic kidney disease; endothelial dysfunction; exercise; l-arginine

Mesh:

Substances:

Year:  2014        PMID: 24966085      PMCID: PMC4214831          DOI: 10.1152/ajprenal.00014.2014

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  55 in total

1.  Can young adult patients with proteinuric IgA nephropathy perform physical exercise?

Authors:  Giorgio Fuiano; Domenico Mancuso; Paola Cianfrone; Nicola Comi; Giuseppe Mazza; Francesco Marino; Laura Fuiano; Pasquale Zamboli; Alfredo Caglioti; Michele Andreucci
Journal:  Am J Kidney Dis       Date:  2004-08       Impact factor: 8.860

2.  Cardiac function and tolerance to ischemia-reperfusion injury in chronic kidney disease.

Authors:  James M Kuczmarski; Christopher R Martens; Shannon L Lennon-Edwards; David G Edwards
Journal:  Nephrol Dial Transplant       Date:  2013-10-22       Impact factor: 5.992

3.  Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure.

Authors:  Katy J Bennett-Richards; Mia Kattenhorn; Ann E Donald; Gillian R Oakley; Zac Varghese; K Richard Bruckdorfer; John E Deanfield; Lesley Rees
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

4.  Oral L-arginine improves endothelial function in healthy individuals older than 70 years.

Authors:  Stefanie M Bode-Böger; Jochen Muke; Andrzej Surdacki; Georg Brabant; Rainer H Böger; Jürgen C Frölich
Journal:  Vasc Med       Date:  2003-05       Impact factor: 3.239

Review 5.  Role of endothelial dysfunction in atherosclerosis.

Authors:  Jean Davignon; Peter Ganz
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

6.  Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.

Authors:  Marcin Adamczak; Marie-Luise Gross; Jan Krtil; Andreas Koch; Karin Tyralla; Kerstin Amann; Eberhard Ritz
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

Review 7.  Role of L-arginine in the pathogenesis and treatment of renal disease.

Authors:  Gautam Cherla; Edgar A Jaimes
Journal:  J Nutr       Date:  2004-10       Impact factor: 4.798

8.  Forearm reactive hyperemia and mortality in end-stage renal disease.

Authors:  Gérard M London; Bruno Pannier; Mohsen Agharazii; Alain P Guerin; Francis H M Verbeke; Sylvain J Marchais
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

9.  Classical isoforms of PKC as regulators of CAT-1 transporter activity in pulmonary artery endothelial cells.

Authors:  Karina Y Krotova; Sergey I Zharikov; Edward R Block
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-01-31       Impact factor: 5.464

Review 10.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

View more
  11 in total

1.  Voluntary wheel running prevents salt-induced endothelial dysfunction: role of oxidative stress.

Authors:  John J Guers; Lauren Kasecky-Lardner; William B Farquhar; David G Edwards; Shannon L Lennon
Journal:  J Appl Physiol (1985)       Date:  2018-12-20

2.  Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease.

Authors:  Ryan M Downey; Peizhou Liao; Erin C Millson; Arshed A Quyyumi; Salman Sher; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-08

3.  Effects of aerobic exercise on vascular function in nondialysis chronic kidney disease: a randomized controlled trial.

Authors:  Danielle L Kirkman; Meghan G Ramick; Bryce J Muth; Joseph M Stock; Ryan T Pohlig; Raymond R Townsend; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-27

4.  Intermittent parathyroid hormone administration attenuates endothelial dysfunction in old rats.

Authors:  John J Guers; Rhonda D Prisby; David G Edwards; Shannon Lennon-Edwards
Journal:  J Appl Physiol (1985)       Date:  2016-11-04

5.  Aerobic exercise training improves endothelial function and attenuates blood pressure reactivity during maximal exercise in chronic kidney disease.

Authors:  Justin D Sprick; Kevin Mammino; Jinhee Jeong; Dana R DaCosta; Yingtian Hu; Doree G Morison; Joe R Nocera; Jeanie Park
Journal:  J Appl Physiol (1985)       Date:  2022-02-10

6.  Aerobic Exercise Attenuates Kidney Injury, Improves Physical Performance, and Increases Antioxidant Defenses in Lungs of Adenine-Induced Chronic Kidney Disease Mice.

Authors:  Débora Melissa Petry Moecke; Gisele Henrique Cardoso Martins; Thaine Cristina Garlet; Kelly Cattelan Bonorino; Marilia Gabriela Luciani; Monique Bion; Barbara Dos Santos; Monique da Silva Gevaerd; Jamil Assreuy Filho; Adair Roberto Soares Dos Santos; Daniella Serafin Couto Vieira; Alcir Luiz Dafre; Deborah de Camargo Hizume Kunzler
Journal:  Inflammation       Date:  2022-06-21       Impact factor: 4.657

7.  Association of Exercise With Vascular Function in Patients With CKD: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Huan Wang; Dengpiao Xie; Lisheng Wu; Liangbin Zhao
Journal:  Front Med (Lausanne)       Date:  2022-07-06

Review 8.  The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise.

Authors:  Christopher R Martens; Danielle L Kirkman; David G Edwards
Journal:  Exerc Sport Sci Rev       Date:  2016-01       Impact factor: 6.230

9.  Elevated Circulating Trimethylamine N-Oxide Levels Contribute to Endothelial Dysfunction in Aged Rats through Vascular Inflammation and Oxidative Stress.

Authors:  Tiejun Li; Yanli Chen; Chaojun Gua; Xiaodong Li
Journal:  Front Physiol       Date:  2017-05-30       Impact factor: 4.566

10.  Voluntary Wheel Running Has Beneficial Effects in a Rat Model of CKD-Mineral Bone Disorder (CKD-MBD).

Authors:  Keith G Avin; Matthew R Allen; Neal X Chen; Shruthi Srinivasan; Kalisha D O'Neill; Ashley D Troutman; Garrison Mast; Elizabeth A Swallow; Mary Beth Brown; Joseph M Wallace; Teresa A Zimmers; Stuart J Warden; Sharon M Moe
Journal:  J Am Soc Nephrol       Date:  2019-09-09       Impact factor: 14.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.